SET A DP Tablet

Set A DP Tablet contains the active components dapagliflozin and sitagliptin, two medications used to treat type 2 diabetes mellitus. They operate through different mechanisms and can be combined to help control blood sugar levels in certain patients.

Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that lowers blood glucose levels and reduces overall blood sugar burden in the body. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that regulates blood glucose levels by stimulating insulin release and reducing glucagon production, a hormone that raises blood sugar. This medication may be particularly beneficial for overweight or obese individuals with type 2 diabetes, as it can help achieve and maintain a healthy body weight.

Set A DP Tablet is indicated for treating type 2 diabetes only and should not be used to treat type 1 diabetes. Individuals with known hypersensitivity or allergy to dapagliflozin, sitagliptin, or other components of this medication should not take it.

The medication is primarily eliminated through the kidneys. Individuals with severe renal impairment or end-stage renal disease should not use this medication.

During periods of illness, surgery, or other stressful situations, there may be an increased risk of developing ketoacidosis, particularly in those taking dapagliflozin. Temporary discontinuation of this medication during such events may be necessary.

Limited data exist on the safety of Set A DP Tablet during pregnancy and breastfeeding. Pregnant or breastfeeding individuals should consult their healthcare provider before using this medication.

Set A DP Tablet is used to treat the following: Type 2 diabetes mellitus Obese individuals with type 2 diabetes

The Set A DP Tablet in the treatment of type 2 diabetes provides a dual therapeutic effect by lowering blood glucose levels through different mechanisms: dapagliflozin reduces glucose reabsorption in the kidneys, leading to increased urinary excretion, while sitagliptin enhances insulin secretion and reduces glucagon production. This approach improves glycemic control, reduces the risk of hypoglycemia, and may offer cardiovascular and renal benefits.

Set A DP Tablet can be administered orally in tablet form. The specific usage instructions may vary depending on the condition being treated and the form of the medication. Oral tablets are typically taken with water, as directed by the healthcare provider.

Set A DP Tablet cause some side effects like all medications, although not everyone will experience them. Serious Upper respiratory tract infections (colds, sore throat) Headache Stomach upset or nausea Diarrhea Hypoglycemia (low blood sugar) Joint pain (arthralgia) Common Genital yeast infections (vaginal or penile) Urinary tract infections (UTIs) Increased urination Thirst Dehydration Low blood pressure (hypotension) Dizziness or lightheadedness Increased levels of cholesterol and blood fats (hyperlipidemia)

If you have prescribed Set A DP Tablet for type 2 diabetes, follow your healthcare provider's instructions carefully. Monitor for unusual symptoms, such as genital or urinary infections, and stay hydrated to prevent dehydration. Be aware of signs of diabetic ketoacidosis and seek medical attention promptly if needed. If you have kidney impairment or use sitagliptin with other diabetes medications, be cautious about potential side effects. Regularly attend follow-up appointments and communicate openly with your healthcare provider about any concerns or questions for a successful and safe diabetes management journey.